Emergent BioSolutions Inc
SWB:ER4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Emergent BioSolutions Inc
SWB:ER4
|
US |
|
P
|
Pernod Ricard SA
XHAN:PER
|
FR |
|
Franklin Financial Services Corp
NASDAQ:FRAF
|
US |
|
P
|
Prosperity Bancshares Inc
F:PPY
|
US |
|
Oneview Healthcare PLC
ASX:ONE
|
IE |
|
S
|
South32 Ltd
JSE:S32
|
AU |
|
S
|
Siemens AG
XHAN:SIE
|
DE |
|
A
|
Amper SA
SWB:APR
|
ES |
|
G
|
GFT Technologies SE
F:GFT
|
DE |
|
Genesis Energy LP
NYSE:GEL
|
US |
|
N
|
Noram Drilling AS
OSE:NORAM
|
NO |
|
Fireweed Metals Corp
F:M0G
|
CA |
|
M
|
Microsoft Corp
XHAN:MSF
|
US |
|
Suntec Real Estate Investment Trust
SGX:T82U
|
SG |
|
AVITA Medical Inc
NASDAQ:RCEL
|
US |
|
B
|
BP PLC
XHAN:BPE5
|
UK |
Bankruptcy Probability
Emergent BioSolutions Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Emergent BioSolutions Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Emergent BioSolutions Inc
NYSE:EBS
|
376.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Emergent BioSolutions Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Emergent BioSolutions Inc has total debt of 573.6m USD. This includes both short-term (0 USD) and long-term (573.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
